Pharma & Biotech

ImmunityBio is capturing significant attention with a series of clinical successes that are reshaping its investment profile. The biotech firm...

A wave of positive analyst sentiment is bolstering the outlook for Assembly Biosciences, with Citizens JMP initiating coverage on the...

The telehealth sector faces renewed scrutiny as Hims & Hers Health finds itself in the crosshairs of US regulators. A...

KalVista Pharmaceuticals finds itself navigating conflicting market currents following the announcement of a significant capital raise. The biotech firm secured...

A remarkable case study from Germany, demonstrating a successful treatment for a severe form of ulcerative colitis, is fueling a...

Shares of gene-editing specialist Intellia Therapeutics have experienced significant momentum, driven by a major late-stage clinical development achievement. Investor enthusiasm...

As the patent protection for its blockbuster drug Jakafi approaches expiration, biopharmaceutical firm Incyte is implementing a two-pronged strategy to...

Shares of Viking Therapeutics experienced a notable upswing this week, climbing 7.4% on Wednesday to close at $26.82. The catalyst...

In a trading session characterized by broad market weakness, Mirati Therapeutics shares demonstrated exceptional resilience. The stock held completely flat,...

As markets experienced volatility in September, heavyweight investors demonstrated significant conviction in Vertex Pharmaceuticals. Both institutional players and corporate insiders...